Clinical Trials

Microwave ablation for cancer

Displaying 3 studies

A Study to Assess the BioTraceIO System for Identifying Tissue Damage from Microwave Thermal Liver Ablation Scottsdale/Phoenix, AZ

The purpose of this study is to evaluate the accuracy of the BioTrace IO during RFA/MWA Transcutaneous procedures.
MARK 1A Series: Percutaneous Microwave Ablation For Patients With Lung Tumor(s) Rochester, MN

The purpose of this study is to evaluate if lung ablation improves clinical outcomes for patients deemed to be surgically high-risk.
Ablation With Confirmation Of Colorectal Liver Metastases (ACCLAIM) Rochester, MN

The purpose of this study is to demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.